Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma
ClinicalTrials.gov study NCT04002622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
ClinicalTrials.gov study NCT05909098. IPD Sharing: NO. Countries: 1. Publications: 0.
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
ClinicalTrials.gov study NCT06526793. IPD Sharing: YES. Countries: 16. Publications: 0.
Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02753062. IPD Sharing: YES. Countries: 1. Publications: 0.
A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT07348575. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07258511. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05535244. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.
ClinicalTrials.gov study NCT01991184. IPD Sharing: Not stated. Countries: 2. Publications: 0.
DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05824585. IPD Sharing: NO. Countries: 2. Publications: 0.
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03749018. IPD Sharing: NO. Countries: 1. Publications: 0.
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT00068523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Value of Memory B Cells Marker (CD27) and Howell Jelly Bodies Detrection in Critically Ill Patients
ClinicalTrials.gov study NCT02108405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05533775. IPD Sharing: YES. Countries: 13. Publications: 0.
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
ClinicalTrials.gov study NCT06442475. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
ClinicalTrials.gov study NCT03825718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL
ClinicalTrials.gov study NCT05440409. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia
ClinicalTrials.gov study NCT04546893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
ClinicalTrials.gov study NCT05107856. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05052528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
ClinicalTrials.gov study NCT05950334. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.